MS
Morgan Stanley Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1226
Playtika
PLTK
$1.4B
|
BN
Brian Nowak
| $3.73 | $7.50 |
101%
upside
| Equal-Weight |
27 Feb ‘24
1 year ago |
|
1227
Fate Therapeutics
FATE
$113M
|
MU
Michael Ulz
| $0.9817 | $7 |
613%
upside
| Equal-Weight |
27 Feb ‘24
1 year ago |
|
1228
Unilever
UL
$154B
|
SS
Sarah Simon
| $62.97 | $48 |
24%
downside
| Underweight |
27 Feb ‘24
1 year ago |
|
1229
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.48B
|
SB
Stephen Byrd
| $28.02 | $30 |
7%
upside
| Overweight |
26 Feb ‘24
1 year ago |
|
1230
C4 Therapeutics
CCCC
$189M
|
TF
Terence Flynn
| $2.66 | $8 |
201%
upside
| Equal-Weight |
26 Feb ‘24
1 year ago |
|
|
OTLY
1231
Oatly Group
OTLY
$528M
|
DM
Dara Mohsenian
| $17.41 | $25 |
44%
upside
| Equal-Weight |
20 Feb ‘24
1 year ago |
|
1232
Cadence Design Systems
CDNS
$93.3B
|
LS
Lee Simpson
| $342.39 | $350 |
2%
upside
| Overweight |
14 Feb ‘24
1 year ago |
|
1233
Principal Financial Group
PFG
$18.4B
|
ND
Nigel Dally
| $82.46 | $75 |
9%
downside
| Underweight |
13 Feb ‘24
1 year ago |
|
1234
TFI International
TFII
$7.71B
|
RS
Ravi Shanker
| $92.91 | $176 |
89%
upside
| Overweight |
12 Feb ‘24
1 year ago |
|
1235
Newell Brands
NWL
$2.48B
|
DM
Dara Mohsenian
| $5.92 | $7.75 |
31%
upside
| Equal-Weight |
12 Feb ‘24
1 year ago |
|
1236
HUB Group
HUBG
$2.23B
|
RS
Ravi Shanker
| $36.43 | $44 |
21%
upside
| Equal-Weight |
12 Feb ‘24
1 year ago |
|
1237
Hershey
HSY
$37.4B
|
PK
Pamela Kaufman
| $184.40 | $183 |
1%
downside
| Underweight |
12 Feb ‘24
1 year ago |
|
1238
Synchrony
SYF
$28.2B
|
JA
Jeffrey Adelson
| $75.68 | $30 |
60%
downside
| Underweight |
8 Feb ‘24
1 year ago |
|
1239
Spirit AeroSystems
SPR
$4.57B
|
KL
Kristine Liwag
| $38.88 | $33 |
15%
downside
| Equal-Weight |
7 Feb ‘24
1 year ago |
|
1240
Eli Lilly
LLY
$679B
|
DP
David Phung
| $756.93 | $805 |
6%
upside
| Overweight |
7 Feb ‘24
1 year ago |
|
1241
Raymond James Financial
RJF
$33.9B
|
MG
Manan Gosalia
| $170.15 | $113 |
34%
downside
| Equal-Weight |
29 Jan ‘24
1 year ago |
|
1242
Novartis
NVS
$239B
|
MP
Mark Purcell
| $123.71 | $114 |
8%
downside
| Equal-Weight |
23 Jan ‘24
1 year ago |
|
1243
GSK
GSK
$81.8B
|
MP
Mark Purcell
| $40.62 | $44 |
8%
upside
| Equal-Weight |
23 Jan ‘24
1 year ago |
|
1244
AstraZeneca
AZN
$246B
|
MP
Mark Purcell
| $79.45 | $85 |
7%
upside
| Overweight |
23 Jan ‘24
1 year ago |
|
1245
Novo Nordisk
NVO
$243B
|
MP
Mark Purcell
| $54.60 | $120 |
120%
upside
| Overweight |
23 Jan ‘24
1 year ago |
|
1246
Afya
AFYA
$1.42B
|
JM
Javier Martinez
| $15.60 | $23 |
47%
upside
| Equal-Weight |
22 Jan ‘24
1 year ago |
|
1247
Driven Brands
DRVN
$2.98B
|
SG
Simeon Gutman
| $18.17 | $14 |
23%
downside
| Equal-Weight |
16 Jan ‘24
1 year ago |
|
1248
VTEX
VTEX
$741M
|
CM
Cesar Medina
| $4.07 | $8 |
97%
upside
| Overweight |
5 Jan ‘24
1 year ago |
|
1249
Televisa
TV
$1.52B
|
CM
Cesar Medina
| $2.85 | $4 |
40%
upside
| Equal-Weight |
5 Jan ‘24
1 year ago |
|
1250
Telefônica Brasil
VIV
$20.1B
|
CM
Cesar Medina
| $12.51 | $11 |
12%
downside
| Equal-Weight |
5 Jan ‘24
1 year ago |
|